Here, we demonstrate that dbDNATM can be optimised for the manufacture of high titre LVV.
Read More
As advanced therapies continue to transform the healthcare landscape, the need for sustainable manufacturing solutions grows more critical. Traditional plasmid DNA (pDNA) production presents costly, resource-intensive challenges, threatening scalability and…
Read More
Sarah Moore In this white paper, authored by Dr Sarah Moore, Head of Gene Therapy Discovery, Touchlight, we discuss major challenges and present approaches to improve overall functional titre, through…
Read More
SARAH MOORE & MARIA BARREIRA With contribution by Helen Horton and Claire KerridgeTraditional bacterial fermentation techniques used to manufacture plasmid are time-consuming, expensive, and inherently unstable. The production of sufficient…
Read More
